199 related articles for article (PubMed ID: 23438481)
1. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition.
Servillo L; Giovane A; Cautela D; Castaldo D; Balestrieri ML
Nitric Oxide; 2013 Apr; 30():43-8. PubMed ID: 23438481
[TBL] [Abstract][Full Text] [Related]
2. Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration.
Alkaitis MS; Nardone G; Chertow JH; Ackerman HC
Biomed Chromatogr; 2016 Mar; 30(3):294-300. PubMed ID: 26130049
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
4. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
5. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase].
Masuda H; Azuma H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754
[TBL] [Abstract][Full Text] [Related]
6. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
MacAllister RJ; Fickling SA; Whitley GS; Vallance P
Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
[TBL] [Abstract][Full Text] [Related]
8. GC-MS and LC-MS/MS pilot studies on the guanidine (N
Bollenbach A; Gambaryan S; Mindukshev I; Pich A; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122024. PubMed ID: 32062367
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine regulates the lipopolysaccharide-induced nitric oxide production in macrophages by suppressing the activation of NF-kappaB and iNOS expression.
Pekarova M; Kubala L; Martiskova H; Bino L; Twarogova M; Klinke A; Rudolph TK; Kuchtova Z; Kolarova H; Ambrozova G; Kuchta R; Kadlec J; Lojek A
Eur J Pharmacol; 2013 Aug; 713(1-3):68-77. PubMed ID: 23665490
[TBL] [Abstract][Full Text] [Related]
10. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.
Leiper J; Vallance P
Cardiovasc Res; 1999 Aug; 43(3):542-8. PubMed ID: 10690326
[TBL] [Abstract][Full Text] [Related]
12. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy.
Bełtowski J; Kedra A
Pharmacol Rep; 2006; 58(2):159-78. PubMed ID: 16702618
[TBL] [Abstract][Full Text] [Related]
15. Production of free methylarginines via the proteasome and autophagy pathways in cultured cells.
Shirakawa T; Kako K; Shimada T; Nagashima Y; Nakamura A; Ishida J; Fukamizu A
Mol Med Rep; 2011; 4(4):615-20. PubMed ID: 21584492
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
18. Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract.
Masuda H; Tsujii T; Okuno T; Kihara K; Goto M; Azuma H
J Urol; 2002 May; 167(5):2235-40. PubMed ID: 11956485
[TBL] [Abstract][Full Text] [Related]
19. HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids.
Teerlink T
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):21-9. PubMed ID: 16931194
[TBL] [Abstract][Full Text] [Related]
20. Developing a robust, fast and reliable measurement method for the analysis of methylarginine derivatives and related metabolites.
Eryavuz Onmaz D; Abusoglu S; Yaglioglu H; Abusoglu G; Unlu A
J Mass Spectrom Adv Clin Lab; 2021 Jan; 19():34-45. PubMed ID: 34820664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
